New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Following the application of epigenetic and epigenomics research into tumor diseases, cardiovascular disease, diabetes, hereditary diseases, and rare diseases, in vitro diagnostics (IVD) epigenetic and epigenomics are increasingly employed for those patients. Here, we review a clinical sampling of epigenetics and epigenomics from patients. We then present procedures, including the detection procedure of clinical epigenetic approaches from clinical samples, clinical epigenomic methods applied to those samples, the small cell number of epigenetics, and epigenomics. Finally, we present the current IVD of epigenetics and epigenomics used for clinical analysis and diagnosis, along with the development of approaches. To improve clinical study and diagnosis, we also introduce clinical research and clinical applications to develop a more comprehensive strategy to maximize the sensitivity and specificity of the epigenetics and epigenomics analysis and diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187 · cited 1×
“Clinical studies have find that lncRNAs are related to metabolism and immunity diseases and are closely related to the occurrence and development of tumors, CVD, nervous system disorders, and nephropathy [19,20].”
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Motzer, R. J., Penkov, K., Haanen, J., Rini, B., Albiges, L., Campbell, M. T., Venugopal, B., Kollmannsberger, C., Negrier, S., Uemura, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816047 · Cited by 2,503
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“…Non-Repressible 5 (GNC5), CREB-binding protein (CBP), P300/CBP-binding protein (PCAF), MYST family, P300, TAFII250, and Rtt109 are increasingly reported in histone modification, which can increase clinical epigenetics analysis and diagnosis to increase epigenetics therapeutic potential [67–74].”
Modification of Enhancer Chromatin: What, How, and Why?
Calo, E., & Wysocka, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.038 · Cited by 1,457
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
The functions and unique features of long intergenic non-coding RNA
Ransohoff, J. D., Wei, Y., & Khavari, P. A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.104 · Cited by 1,330
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Asangani, I. A., Dommeti, V. L., Wang, X., Malik, R., Cieslik, M., Yang, R., Escara-Wilke, J., Wilder-Romans, K., Dhanireddy, S., Engelke, C., et al. (2014) · Nature · doi:10.1038/nature13229 · Cited by 927
Pal, S., & Tyler, J. K. (2016) · Science Advances · doi:10.1126/sciadv.1600584 · Cited by 860
Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis
Hsiao, K.-Y., Lin, Y.-C., Gupta, S. K., Chang, N., Yen, L., Sun, H. S., & Tsai, S.-J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1883 · Cited by 669
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature · doi:10.1038/nature16508 · Cited by 632
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells
Liao, J., Karnik, R., Gu, H., Ziller, M. J., Clement, K., Tsankov, A. M., Akopian, V., Gifford, C. A., Donaghey, J., Galonska, C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3258 · Cited by 476
Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat
Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405
Zhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J., & Rothenberg, E. V. (2012) · Cell · doi:10.1016/j.cell.2012.01.056 · Cited by 337 · cited 1×
“Moreover, histone modifications (PTM) detection by mass spectrometry (MS) has been used in clinical patients [43–46].”
ncRNA-Encoded Peptides or Proteins and Cancer
Wang, J., Zhu, S., Meng, N., He, Y., Lu, R., & Yan, G.-R. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.001 · Cited by 330
The BET family in immunity and disease
Wang, N., Wu, R., Tang, D., & Kang, R. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00384-4 · Cited by 295
Exploring the mechanisms behind long noncoding RNAs and cancer
Balas, M. M., & Johnson, A. M. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.03.001 · Cited by 288
Liu, F., Killian, J. K., Yang, M., Walker, R. L., Hong, J. A., Zhang, M., Davis, S., Zhang, Y., Hussain, M., Xi, S., et al. (2010) · Oncogene · doi:10.1038/onc.2010.129 · Cited by 273
BRD4 is a novel therapeutic target for liver fibrosis
Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Dragomir, M. P., Kopetz, S., Ajani, J. A., & Calin, G. A. (2020) · Gut · doi:10.1136/gutjnl-2019-318279 · Cited by 211
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Sadeh, R., Sharkia, I., Fialkoff, G., Rahat, A., Gutin, J., Chappleboim, A., Nitzan, M., Fox-Fisher, I., Neiman, D., Meler, G., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00775-6 · Cited by 179
Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer.
Zhao, W. M., An, Y., Liang, Y., & Xw, X. (2014) · PubMed · Cited by 109
Anderson, L., & Pennell, D. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn189 · Cited by 108
Fedyuk, V., Erez, N., Furth, N., Beresh, O., Andreishcheva, E. N., Shinde, A., Jones, D. R., Zakai, B. B., Mavor, Y., Peretz, T., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01447-3 · Cited by 98
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
El Fatimy, R., Subramanian, S., Uhlmann, E. J., & Krichevsky, A. M. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.004 · Cited by 97
Modulation of miRNA function by natural and synthetic RNA-binding proteins in cancer
Vos, P. D., Leedman, P. J., Filipovska, A., & Rackham, O. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03163-9 · Cited by 84
RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing
Khan, D. H., Gonzalez, C., Cooper, C., Sun, J.-M., Chen, H. Y., Healy, S., Xu, W. W., Smith, K. T., Workman, J. L., Leygue, E., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1134 · Cited by 71
Russ, B. E., Olshansky, M., Li, J., Nguyen, M. L. T., Gearing, L. J., Nguyen, T. H. O., Olson, M. R., McQuilton, H. A., Nüssing, S., Khoury, G., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.097 · Cited by 65
Airway epithelial cells as drivers of severe asthma pathogenesis
Dorscheid, D. R., Gauvreau, G. M., Georas, S. N., Hiemstra, P. S., Varricchi, G., Lambrecht, B. N., & Marone, G. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.03.003 · Cited by 61
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency
Guo, T., Liu, H., Xu, B., Qi, Y., Xu, K., Wu, X., He, X., Qin, Y., & Chen, Z. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf011 · Cited by 57
Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy
Varela, M. A., Roberts, T. C., & Wood, M. J. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0212-7 · Cited by 54
Wang, N., Yu, Y., Xu, B., Zhang, M., Li, Q., & Miao, L. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9721 · Cited by 48
Stenzig, J., Hirt, M. N., Löser, A., Bartholdt, L. M., Hensel, J.-T., Werner, T., Riemenschneider, M., Indenbirken, D., Guenther, T., Müller, C., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0528-z · Cited by 40
Assis, R. I. F., Wiench, M., Silvério, K. G., da Silva, R. A., Feltran, G. D. S., Sallum, E. A., Casati, M. Z., Nociti, F. H., & Andia, D. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207873 · Cited by 32
Domaszewska-Szostek, A., Krzyżanowska, M., Polak, A., & Puzianowska-Kuźnicka, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052354 · Cited by 32
Associations of socioeconomic disparities with buccal DNA-methylation measures of biological aging
Raffington, L., Schwaba, T., Aikins, M., Richter, D., Wagner, G. G., Harden, K. P., Belsky, D. W., & Tucker–Drob, E. M. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01489-7 · Cited by 30
Mukhopadhyay, P., Greene, R. M., & Pisano, M. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.10.009 · Cited by 27
Khan, D. H., Healy, S., He, S., Lichtensztejn, D., Klewes, L., Sharma, K. L., Lau, V., Mai, S., Delcuve, G. P., & Davie, J. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-08-0618 · Cited by 23
van Dongen, J., Willemsen, G. A. H. M., de Geus, E. J. C., Boomsma, D. I., & Neale, M. C. (2023) · eLife · doi:10.7554/elife.83286 · Cited by 21
Liquid Biopsies in the Early Diagnosis, Prognosis, and Tailored Treatment of Colorectal Cancer
Liatsou, Ε., Kollias, I., Trapali, M., Tsilimigras, D. I., Gavriatopoulou, M., & Ntanasis‐Stathopoulos, I. (2025) · Cancers · doi:10.3390/cancers17060927 · Cited by 19
Wang, F., Wen, J., Liu, J., Xin, L., Fang, Y., Sun, Y., & He, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556764 · Cited by 14
Qin, H., Qi, T., Xu, J., Wang, T.-B., Zeng, H., Yang, J., & Yu, F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1446522 · Cited by 13
Banimohammad, M., Khalafi, P., Gholamin, D., Bangaleh, Z., Akhtar, N., Solomon, A. D., Prabhakar, P. K., Sanami, S., Prakash, A., & Pazoki–Toroudi, H. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002306 · Cited by 12
Systems epigenetic approach towards non-invasive breast cancer detection
Herzog, C. M. S., Theeuwes, B., Jones, A., Evans, I., Bjørge, L., Zikán, M., Cibula, D., Harbeck, N., Colombo, N., Pashayan, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-53696-2 · Cited by 12
Alberto-Aguilar, D. R., Hernández‐Ramírez, V. I., Osorio‐Trujillo, J. C., Gallardo‐Rincón, D., Toledo‐Leyva, A., & Talamás‐Rohana, P. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02425-6 · Cited by 10
Emilia, A. G., Marcu, A., Moatăr, A. I., Samoilă, C., Podariu, A. C., Șeclăman, E. P., & Marian, C. (2020) · Journal of International Medical Research · doi:10.1177/0300060520954677 · Cited by 9
Campen, H. V., Bishop, J. V., Brink, Z., Engle, T. E., Gonzalez-Berrios, C. L., Georges, H. M., Kincade, J. N., Murtazina, D. A., & Hansen, T. R. (2024) · Viruses · doi:10.3390/v16050721 · Cited by 9
Ko, H., Ahn, H. J., & Kim, Y. I. (2021) · Oncology Reports · doi:10.3892/or.2021.8248 · Cited by 8
Yang, R., Liu, N., Li, T., Liu, F., Zhang, J., Zhao, H., Zou, L., & He, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04535-3 · Cited by 8
Huang, H., Jin, H., Lei, R., He, Z., He, S., Chen, J., Saw, P. E., Qiu, Z., Ren, G., & Nie, Y. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0334 · Cited by 7
Cintron, M., Baumer, Y., Pang, A. P. S., Peterson, E. M. A., Ortiz-Whittingham, L. R., Jacobs, J. A., Sharda, S., Potharaju, K. A., Baez, A. S., Gutierrez‐Huerta, C. A., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100976 · Cited by 7
LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa
Felice, B. D., Luca, P. D., Montanino, C., Mallardo, M., Babino, G., Mattera, E., Sorbo, R., Ragozzino, G., Argenziano, G., Daniele, A., et al. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13236 · Cited by 6
Handoko, H., Adham, M., Rachmadi, L., Tobing, D. L., Asmarinah, A., Fadilah, F., Dai, W., Lee, A., & Gondhowiardjo, S. A. (2025) · Biologics · doi:10.2147/btt.s490382 · Cited by 6
A Cross-Generational Methylomic Signature of Infant Maltreatment in Newborn Rhesus Macaques
Lardenoije, R., Smulders, M. N. C. A., Morin, E. L., Howell, B., Guzman, D., Meyer, J. S., Ressler, K. J., Sánchez, M., & Klengel, T. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.901 · Cited by 6
Li, Y., Chen, Y., Liu, Z., Liu, Z., Xu, F., Song, D., Che, K., Chen, D., Xu, W., Li, W., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109618 · Cited by 5
Huang, X., Lu, J., Zhang, Y., Qiu, J., & Yao, G. (2024) · Journal of Cancer Science and Clinical Therapeutics · doi:10.26502/jcsct.5079244 · Cited by 5
Perinatal asphyxia and Alzheimer's disease: is there a correlation?
Arruda, B. P., Martins, P. P., Kihara, A. H., & Takada, S. H. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1567719 · Cited by 5
The effect of 1,25(OH)2D3 on Dickkopf-1 methylation in colorectal cancer
Sun, H., Yang, L., Li, N., Hu, Y., Hu, Q., Zhou, Z., & Cong, X. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01857-5 · Cited by 5
Nagao, Y., Fujimoto, M., Tian, Y., Kameyama, S., Hattori, K., Hidese, S., Kunugi, H., Kanai, Y., & Arai, E. (2025) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.240126 · Cited by 5
"Machine-learning Modeling for Personalized Immunotherapy- An Evaluation Module"
Li, Y. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.47.007462 · Cited by 4
Moeng, S., Chamorro, A., Jeon, M. S., Cai, J. J., & Ramos, K. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041690 · Cited by 4
Xia, L., Luo, X., Liang, Y., Jiang, X., Yang, W., Yan, J., Qi, K., & Li, P. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01108-6 · Cited by 4
Editorial: Epigenetics in cancer: mechanisms and drug development-volume II
Zhu, X. M., Xu, Z., & Li, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1242960 · Cited by 3
Dual targeting of CXCR4 and EZH2 in endometriosis
Brunty, S., Wagner, K., Fleshman, T., Ruley, M., Mitchell, B. L., & Santanam, N. (2025) · iScience · doi:10.1016/j.isci.2025.112143 · Cited by 3
Janik, K., Jin, L., Kyzy, K. Z., Kaminski, R., Smith, G. M., & Krynska, B. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115231 · Cited by 3
Osborne, T. F., Jaiswal, A., Halász, L., & Williams, D. L. (2025) · Research Square · doi:10.21203/rs.3.rs-6702384/v1 · Cited by 3
ImmunoMet Oncogenesis: A New Concept to Understand the Molecular Drivers of Cancer
Sirajee, R., Khatib, S. E., Dieleman, L. A., Salla, M., & Baksh, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051620 · Cited by 2
Liu, Y., Teng, X., Bai, D., Fu, X., Chang, Q., Li, J., Gao, S., Liu, W., & Guo, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142130 · Cited by 2
Differential H3K4me3 Domains in Normal and Colorectal Cancer Cells Reveal Novel Epigenetic Targets
Bahia, R. K., Lopez, C. L., Nardocci, G., & Davie, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062546 · Cited by 2
Li, Y. (2017) · International Journal of Hematology and Therapy · doi:10.15436/2381-1404.17.016 · Cited by 1
Editorial: Epigenetics in Cancer: Mechanisms and Drug Development
Yuan, H., Huang, Y., Tao, S., Li, Y., Xu, Z., Qi, Y., Wu, B., Luo, H., & Zhu, X. M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.831704 · Cited by 1
Hebert, K. J., Bruno, A. M., Matta, R., Horns, J. J., Paudel, N., Das, R., Hotaling, J. M., McCormick, B., & Myers, J. B. (2023) · Urology · doi:10.1016/j.urology.2023.09.032 · Cited by 1
Alemán, A., Adrien, L., Lopez-Serra, L., Cordón-Cardó, C., Esteller, M., Belbin, T. J., & Sänchez‐Carbayo, M. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02903-4 · Cited by 1
Differential H3K4me3 Domains in Normal and Colorectal Cancer Cells Reveal Novel Epigenetic TargetsPreprint
Bahia, R. K., Lopez, C. L., Nardocci, G., et al. (2025) · Preprints.org · doi:10.20944/preprints202502.1369.v1 · Cited by 1
Jaiswal, A., Halász, L., Williams, D. L., & Osborne, T. F. (2025) · SSRN Electronic Journal · doi:10.1101/2025.03.18.644013 · Cited by 1
Cited by
Epigenetic regulation of circulating tumor cells in precision oncology
Farah, H. S., Abosaoda, M. K., Mousa, H. M., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., Singh, G., & Chauhan, A. S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156282 · Cited by 3
Kac, E., Qi, Q., & Ryznar, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1769422 · Cited by 1
An epigenetic perspective on neonatal encephalopathy with suspected hypoxic ischaemic encephalopathy
Mistry, P., Mellet, J., Durandt, C., Smuts, I., & Pepper, M. S. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01984-z · Cited by 1
Manso, J., Sardone, D., Marotta, V., Salcuni, A. S., Brunetti, A., Cipri, C., Sciannimanico, S. M., Piva, L., Carpentieri, M. S., Falchetti, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021116
Epigenetics and Health Inequities in Indigenous, Black, and Hispanic Communities
Shi, K. (2026) · Scholarly review . · doi:10.70121/001c.163222
Metadata
- Authors
- Song, P., & Li, B.
- Affiliations
- Zhejiang Chinese Medical University (CN)
- School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2025-06-17
- Volume
- 15
- Issue
- 12
- Pages
- 1539
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC12192280
- OpenAlex
- W4411377817
- Cited by
- 4
- References
- 77
- Citations by year
- 2026: 3 · 2025: 1
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- in vitro diagnostics, precision medicine, epigenetic biomarkers, epigenomic biomarkers, clinical sample analysis, sensitivity and specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.